Showing results (191-200 of 421) with videos related to
Sort By:
Pageof 43
British Journal of Haematology|June 10, 2000
IgG-secreting lymphoplasmacytoid leukaemia: a B-cell disorder with extensively mutated VH genes undergoing Ig isotype-switching frequently associated with trisomy 12R Garand, S S Sahota, H Avet-Loiseau, et al.The Journal of Experimental Medicine|October 1, 1993
Molecular characterization of a cross-reactive idiotope on human immunoglobulins utilizing the VH4-21 gene segmentK N Potter, Y Li, V Pascual, et al.Immunology|June 9, 1998
Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human diseaseD Zhu, C van Arkel, C A King, et al.Leukemia|September 20, 2014
MiR-29b replacement inhibits proteasomes and disrupts aggresome+autophagosome formation to enhance the antimyeloma benefit of bortezomibS Jagannathan, N Vad, S Vallabhapurapu, et al.Seminars in Oncology|December 12, 2001
Novel therapies targeting the myeloma cell and its bone marrow microenvironmentT Hideshima, D Chauhan, K Podar, et al.Leukemia|June 26, 2014
CSNK1α1 mediates malignant plasma cell survivalY Hu, W Song, D Cirstea, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1997
Blockade of mitogen-activated protein kinase cascade signaling in interleukin 6-independent multiple myeloma cellsA Ogata, D Chauhan, M Urashima, et al.European Journal of Haematology. Supplementum|January 1, 1989
Autologous bone marrow transplantation therapy for multiple myelomaK C Anderson, B A Barut, J Ritz, et al.Journal of Hematotherapy|May 23, 1998
Sequential CD34+ and CD4+ cell selection from leukapheresis componentsI J Webb, M Beach, J F Daley, et al.Cancer Treatment Reviews|June 1, 1989
A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinomaT J Hamblin, V Inzani, S Sadullah, et al.Pageof 43